Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biodel

Biodel?uq=BoBgMMEs
2003 FOUNDED
M&A STATUS
31-40 EMPLOYEES
M&A LATEST DEAL TYPE
11 FINANCING ROUNDS
Description

Developer of innovative treatments for endocrine disorders such as diabetes and osteoporosis. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Former Stock Listing
ALBO
Primary Office
  • 100 Saw Mill Road
  • Danbury, CT 06810
  • United States

Biodel Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biodel‘s full profile, request access.

Request full access to PitchBook

Biodel Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Biodel‘s full profile, request access.

Request full access to PitchBook

Biodel Executive Team (8)

Name Title Board
Seat
Contact
Info
Paul Bavier General Counsel & Chief Compliance Officer
Arlene Morris Director

6 Former Executives

You’re viewing 2 of 8 executives. Get the full list »

Biodel Board Members (10)

Name Representing Role Since Contact
Info
00000 00000000 00.0 Self Board Member 000 0000
00000 0000000 00 Self Chairman 000 0000
0000000 0000000 00 Self Board Member 000 0000
000000 000000 00 Self Board Member 000 0000
00000 00000 Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »